MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on November 14, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 14, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Disseminated Pneumocystis carinii in a patient receiving aerosolized pentamidine prophylaxis.
Radiographic distribution of Pneumocystis carinii pneumonia in patients with AIDS treated with prophylactic inhaled pentamidine.
[Ultrasonic nebulised pentamidine for Pneumocystis carinii pneumonia].
Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial.
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.
Inhaled pentamidine and prevention of Pneumocystis pneumonia.
Alteration of the natural history of Pneumocystis carinii infection in patients with acquired immunodeficiency syndrome receiving aerosolized pentamidine.
[The prevention of Pneumocystis carinii pneumonia by pentamidine inhalation].
Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks.
Aerosolized pentamidine and Pneumocystis carinii pneumonia: patient compliance and outcomes.
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia.
Domiciliary nebulized pentamidine for secondary prophylaxis against Pneumocystis carinii pneumonia.
Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia.
Prophylaxis of AIDS-related Pneumocystis carinii pneumonia with aerosolized pentamidine in a patient with hypersensitivity to systemic pentamidine.
High pentamidine levels associated with hypoglycemia and azotemia in a patient with Pneumocystis carinii pneumonia.
Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.
Short course of aerosol pentamidine as treatment of Pneumocystis carinii pneumonia in AIDS.
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.
Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy.
Pneumocystis carinii, an opportunist in immunocompromised patients.
Incidence of QT interval prolongation during pentamidine therapy of Pneumocystis carinii pneumonia.
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.
Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial.
Pneumocystis carinii choroiditis in patients receiving inhaled pentamidine.
The New England Journal of Medicine Downloaded from nejm.org on November 14, 2015. For personal use only. No other uses without permission. Copyright...
2MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Disseminated Pneumocystis carinii in a patient receiving aerosolized pentamidine prophylaxis.
Radiographic distribution of Pneumocystis carinii pneumonia in patients with AIDS treated with prophylactic inhaled pentamidine.
[Ultrasonic nebulised pentamidine for Pneumocystis carinii pneumonia].
Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial.
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.
Inhaled pentamidine and prevention of Pneumocystis pneumonia.
Alteration of the natural history of Pneumocystis carinii infection in patients with acquired immunodeficiency syndrome receiving aerosolized pentamidine.
[The prevention of Pneumocystis carinii pneumonia by pentamidine inhalation].
Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks.
Aerosolized pentamidine and Pneumocystis carinii pneumonia: patient compliance and outcomes.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms